A Review of Unmet Needs and Ways to Provide Optimal Care in Multiple Myeloma
Episodes
Specialty:
All
All AI for Oncology Biosimilars Brain Cancer Breast Cancer CAR T-Cell Therapy Disparities in Cancer Care Gastrointestinal Cancer Genitourinary Cancers Global Oncology Graft-vs-Host Disease Gynecologic Oncology Head & Neck Cancers Hematologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Oncology Business Management Pediatric Oncology Precision Medicine in Oncology® Sarcomas Supportive Care
EP. 1: Multiple Myeloma: Challenges in Diagnosis and Role of Multidisciplinary Care By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Joseph Mikhael, MD, Translational Genomics Research Institute, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Katie Joyner, Myeloma Patients Europe Opening its discussion on key unmet needs in multiple myeloma management, a panel of experts discuss key challenges faced when diagnosing patients with multiple myeloma and review the impact of having a multidisciplinary care team.
EP. 2: Educating on Multiple Myeloma: Patient and Physician Resources By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Shared insight from key opinion leaders on educational resources made available to physicians and patients, respectively, regarding multiple myeloma management.
EP. 3: Role of Diagnostic Testing in Patients with Multiple Myeloma By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Experts in multiple myeloma management consider essential tests that aid in the diagnosis and treatment of newly presenting patients.
EP. 4: Treatment Considerations for Patients with Newly Diagnosed Multiple Myeloma By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma.
EP. 5: Treatment for Newly Diagnosed Multiple Myeloma: Addressing Disparities in Care By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Comprehensive insight to disparities that may impact a patient’s access to therapy for multiple myeloma and how these may be overcome.
EP. 6: Educating Patients on Treatment Options for Multiple Myeloma By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Expert panelists consider best methods in educating patients on their options for therapy following a diagnosis of multiple myeloma.
EP. 7: Multiple Myeloma: Regulatory Aspects of Treatment Development and Approval By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe A focused discussion on the regulatory aspects of drug testing and approval, globally, with respect to the setting of multiple myeloma management.
EP. 8: Importance of Clinical Trial Enrollment in Multiple Myeloma By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Key opinion leaders in multiple myeloma management elucidate the value of clinical trials and share enthusiasm for improving enrollment when possible.
EP. 9: Impact of Clinical Trials on the Management of Multiple Myeloma By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Continuing its discussion on clinical trials in multiple myeloma, the panel emphasizes the impact that data may have on the real-world treatment landscape.
EP. 10: Holistic and Multidisciplinary Approaches to Multiple Myeloma Management By Faith E. Davies, MD, NYU Langone's Perlmutter Cancer Center, Beth M. Faiman, PhD, MS, APN-BC, BMTCN, AOCN, FAAN, FAPO, Joseph Mikhael, MD, Translational Genomics Research Institute, Katie Joyner, Myeloma Patients Europe Closing out their program on multiple myeloma, expert panelists consider the role of holistic and multidisciplinary care when managing patients within the current paradigm.
